MY ABPI LOGIN
 
Tags - WeWontRest

UK steps up its role in fighting global AMR

With 10 million people a year projected to die from antibiotic-resistant infections by 2050, it’s important that all partners, including the pharmaceutical industry, step up and work together to tackle this issue.

Janssen: Shaping the future of cancer treatment & care

“I won’t rest until we manage to deliver solutions that make blood cancer a manageable or even curable condition.” - Dr Catherine Taylor, Therapy Area Lead; Haemotology; Janssen Oncology; Europe, Middle East, Africa.

Six scientists that save the world every day - and why the UK needs more of them

Have you ever wondered if the scientists you see in movies that are racing against the clock to prevent a deadly disease breakout actually exist?

Career profile: Bioinformatician

Genomics is already delivering precision treatments to patients with remarkable speed: the landscape of life sciences is changing and it’s being driven by information.

Will biosimilars revolutionise the future of health?

The ABPI represents UK-based pharma companies researching the newest and most innovative medicines. Our members make both originator biological medicines and make biosimilar medicines so, for want of a better word, we have a foot in both camps.
;